Literature DB >> 33394375

Distinguishing Parathyromatosis, Atypical Parathyroid Adenomas, and Parathyroid Carcinomas Utilizing Histologic and Clinical Features.

Jefree J Schulte1,2, Garrison Pease3, Jerome B Taxy4, Curtis Hall4, Nicole A Cipriani5.   

Abstract

Parathyromatosis is displaced parathyroid tissue in the neck and mediastinum related to prior surgery. Parathyromatosis can be difficult to distinguish from atypical adenoma and parathyroid carcinoma. The aim of this study is to evaluate clinical and morphologic features that may differentiate parathyromatosis, atypical adenoma, and parathyroid carcinoma. Cases of parathyromatosis, atypical adenoma, and parathyroid carcinoma were identified. Index cases were reviewed by consensus for histologic features, including stromal, cytologic/architectural, and invasive features. Ki67 was performed on index cases and scored using the Adsay method. Clinical information was gathered from the electronic medical record. 4 parathyromatosis, 17 atypical adenoma, and 6 parathyroid carcinoma were included. Parathyroid carcinomas were more likely to display coarse chromatin with nucleoli (P = 0.04), infiltrative invasion (P < 0.01), and metastasis (P < 0.01). Only parathyromatosis showed circumscribed invasion. Infiltrative invasion was more common in cases with progression (P = 0.046) and metastasis (P < 0.001). Necrosis and perineural invasion were only present in cases with progression and were more frequent in cases with metastasis (P = 0.079 and P = 0.19, respectively). There were no differences in presence of a fibrous capsule, capsular invasion, intralesional fibrous bands, random endocrine atypia, solid growth, Ki67 index, gland size/weight, serum PTH/calcium levels, and locoregional recurrence rates. There is overlap in the histologic features in parathyromatosis, atypical adenoma, and parathyroid carcinoma. While perineural, vascular, and infiltrative soft tissue invasion should remain diagnostic of malignancy, other atypical features such as solid growth, coarse chromatin with nucleoli, and necrosis should raise concern for recurrence and/or metastasis, and can be present in parathyroid lesions with and without recurrence.
© 2021. This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply.

Entities:  

Keywords:  Atypical parathyroid adenoma; Parathyroid carcinoma; Parathyromatosis

Mesh:

Year:  2021        PMID: 33394375      PMCID: PMC8384997          DOI: 10.1007/s12105-020-01281-6

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  42 in total

1.  The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Authors:  Géza Mózes; Kathleen J Curlee; Charles M Rowland; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant; David R Farley
Journal:  J Am Coll Surg       Date:  2002-02       Impact factor: 6.113

2.  Parathyroid carcinoma. A study of 70 cases.

Authors:  A Schantz; B Castleman
Journal:  Cancer       Date:  1973-03       Impact factor: 6.860

Review 3.  Molecular pathogenesis of parathyroid tumours.

Authors:  Luigia Cinque; Flavia Pugliese; Antonio Stefano Salcuni; Alfredo Scillitani; Vito Guarnieri
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2018-11-20       Impact factor: 4.690

Review 4.  Parathyroid carcinoma: an overview.

Authors:  Ronald A DeLellis
Journal:  Adv Anat Pathol       Date:  2005-03       Impact factor: 3.875

5.  Parathyroid tumors and related disorders.

Authors:  Ronald A DeLellis
Journal:  Mod Pathol       Date:  2011-04       Impact factor: 7.842

Review 6.  Clinical presentation, staging and long-term evolution of parathyroid cancer.

Authors:  Nadia Talat; Klaus-Martin Schulte
Journal:  Ann Surg Oncol       Date:  2010-03-10       Impact factor: 5.344

7.  Loss of parafibromin immunoreactivity is a distinguishing feature of parathyroid carcinoma.

Authors:  Min-Han Tan; Carl Morrison; Pengfei Wang; Ximing Yang; Carola J Haven; Chun Zhang; Ping Zhao; Maria S Tretiakova; Eeva Korpi-Hyovalti; John R Burgess; Khee Chee Soo; Wei-Keat Cheah; Brian Cao; James Resau; Hans Morreau; Bin Tean Teh
Journal:  Clin Cancer Res       Date:  2004-10-01       Impact factor: 12.531

Review 8.  Parathyroid carcinoma: clinical and pathologic features in 43 patients.

Authors:  A G Wynne; J van Heerden; J A Carney; L A Fitzpatrick
Journal:  Medicine (Baltimore)       Date:  1992-07       Impact factor: 1.889

9.  Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?

Authors:  P S Randhawa; A D Mace; S A R Nouraei; M P Stearns
Journal:  Clin Otolaryngol       Date:  2007-06       Impact factor: 2.597

10.  Parathyroid carcinoma: evaluation and interdisciplinary management.

Authors:  Gary L Clayman; Hernan E Gonzalez; Adel El-Naggar; Rena Vassilopoulou-Sellin
Journal:  Cancer       Date:  2004-03-01       Impact factor: 6.860

View more
  2 in total

Review 1.  Overview of the 2022 WHO Classification of Parathyroid Tumors.

Authors:  Lori A Erickson; Ozgur Mete; C Christofer Juhlin; Aurel Perren; Anthony J Gill
Journal:  Endocr Pathol       Date:  2022-02-17       Impact factor: 3.943

2.  Parathyroid Crisis as Presentation of Atypical Parathyroid Adenoma: Two Diagnostically Challenging Cases.

Authors:  Galo Andrés Salvador Landeta; Alexis Trejo Montes; Tania Islem Gamboa Jimenéz; Vargas-Ortega Guadalupe; González-Virla Baldomero; Balcázar-Hernández Lourdes
Journal:  J Bone Metab       Date:  2022-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.